gracecast-035_lung-cancer_thought leader round table part 1
Published 14 years ago • 210 plays • Length 10:03Download video MP4
Download video MP3
Similar videos
-
9:22
gracecast-036_lung-cancer_thought leader round table part 2
-
14:52
gracecast-031_lung-cancer_treatment - past, present, and future
-
16:39
gracecast-067_lung-cancer_expert round table - nsclc molecular markers case 3
-
10:57
gracecast-033_lung-cancer_individualizing treatment for nsclc
-
15:20
gracecast-057_lung-cancer_expert round table - optimal nsclc treatment for elderly / frail
-
35:48
gracecast-055_lung-cancer_expert round table - adjuvant therapy for elderly / frail
-
9:36
gracecast-021_lung-cancer_stage iiia management options
-
6:41
gracecast-123_rad_refining radiation therapy for lc, pt 3: recent successes and open questions
-
17:28
gracecast-098_lung-cancer_mm in lc pt 3: who to test and what to test for -- panel discussion
-
8:14
gracecast-048_lung-cancer_expert round table - tsao & farivar case 3
-
17:15
gracecast-043_lung-cancer_expert round table - tsao farivar bac 1
-
20:06
gracecast-065_lung-cancer_expert round table - nsclc molecular markers
-
17:58
gracecast-058_lung-cancer_expert round table - stage iiia n2 node-positive options
-
13:38
gracecast-056_lung-cancer_expert round table - managing nsclc for elderly / frail
-
16:57
gracecast-061_lung-cancer_expert round table - stage iiib nsclc curative intent limits
-
18:08
gracecast-051_lung-cancer_ramalingam on first line nsclc therapy q&a
-
15:41
gracecast-059_lung-cancer_expert round table - ambiguous imaging results after chemo/radiation
-
21:33
optimal ngs platforms, how to interpret - grace targeted therapies in lung cancer patient forum 2021
-
24:30
gracecast-100_lung-cancer_mm in lc pt 5: dr. spigel on incorporating targets into clinical trials